Can the DEA outlaw CBD?! | news nug recap | CoralReefer
Check on YouTube
Check on YouTube
Check on YouTube
Check on YouTube
Scientific understanding of the role of the endocannabinoid system in modulating human health continues to expand, including in areas where this vast network of receptors and signaling molecules gets little, if any, attention outside academic […]
This week’s newsletter covers a major CBD product recall, surprising findings about “magic mushroom” edibles, promising preclinical research on CBD for metabolic health, acupuncture’s link to the endocannabinoid system, and a review of psychedelic-associated depersonalization […]
This week’s newsletter covers Uruguay’s landmark move to integrate CBD into its national healthcare system, a historical review of endocannabinoid science, and the latest research on CBD’s potential for Alzheimer’s disease, skin conditions, and chronic […]
This week’s newsletter covers promising CBD research for Alzheimer’s disease and leukemia, the neuroprotective power of combining CBD with antioxidants, new findings on long-term ayahuasca use and emotional resilience, and a critical look at Trump’s […]
This week’s newsletter covers critical analysis of RFK Jr.’s approach to public health and pesticide reform, the endocannabinoid system’s vulnerability to chemical pollutants, and the FDA’s contradictory stance on CBD edibles. Noteworthy Read MAHA Won’t […]
This week’s newsletter covers psychedelic turf wars erupting in Toronto’s grey market, ketamine therapy concerns among law enforcement, ayahuasca’s potential misuse for political influence in Brazil, Silicon Valley’s growing consolidation of the psychedelic industry, and […]
This week’s newsletter covers promising new research on CBD’s therapeutic potential for cancer patients, quality control concerns with commercial CBD products, a significant hemp regulation court ruling, and CBD’s emerging role in regenerative medicine. Noteworthy […]
© Copyright 2018-2026 HempEtCetera.com, Hemp Et Cetera™ is a unit of SoCal Broadband Inc. All rights reserved.